Calculation of ÉLAN-HF (European coLlaboration on Acute decompeNsated Heart Failure) score
| Predictors | Score for 180-day mortality* | Regression coefficient |
|---|---|---|
| NT-proBNP reduction, % | ||
| ≤30 | 1 | 0.511 |
| NT-proBNP discharge value, pg/mL | ||
| 1500–5000 | 1 | 0.713 |
| 5001–15 000 | 3 | 1.426 |
| >15 000 | 4 | 1.776 |
| Age at admission, years | ||
| ≥75 | 1 | 0.345 |
| Peripheral oedema at admission | ||
| Yes | 1 | 0.517 |
| SBP at admission, mm Hg | ||
| ≤115 | 1 | 0.431 |
| Hyponatremia at admission, mmol/L† | ||
| <135 | 1 | 0.374 |
| Serum urea at discharge, mmol/L | ||
| ≥15 | 1 | 0.486 |
| NYHA Class at discharge III/IV | ||
| Yes | 1 | 0.403 |
*Maximum penalty point in the ÉLAN-HF risk score is equal to 11.
†Hyponatremia was defined as sodium <135 mmol/L.
NT-proBNP, N-terminal pro-B-type natriuretic peptide; NYHA, New York Heart Association; SBP, systolic blood pressure.